MEDP241220C210000
- 0.00
- 0.000.00%
Medpace Newsroom
Is It Time To Consider Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Medpace Holdings Is Maintained at Neutral by Baird
Medpace Hldgs Analyst Ratings
Baird Maintains Medpace(MEDP.US) With Hold Rating, Raises Target Price to $354
Medpace Price Target Raised to $354 From $349 at Baird
Express News | Medpace Holdings Inc : Baird Raises Target Price to $354 From $349
Insiders At Medpace Holdings Sold US$525m In Stock, Alluding To Potential Weakness
Wolf Haldenstein Adler Freeman & Herz LLP Announces That It Is Investigating Medpace Holdings, Inc. for Potential Violations of Securities Laws
Medpace Holdings, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Announces Target Price $347
TD Cowen Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $372
Medpace Holdings Is Maintained at Buy by TD Cowen
Express News | TD Cowen Maintains Buy on Medpace Hldgs, Lowers Price Target to $372
Earnings Call: Medpace Reports Growth Amidst Increased Cancellations
This McDonald's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Express News | Medpace Holdings Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results
Baird Downgrades Medpace(MEDP.US) to Hold Rating, Cuts Target Price to $349
Medpace Downgraded to Neutral From Outperform at Baird
Optimistic Outlook for Medpace Holdings Amid Strong Financial Performance and Strategic Initiatives
Express News | Medpace Holdings Inc : Jefferies Cuts Target Price to $305 From $345